Penile squamous cell carcinoma is genomically similar to other HPV-driven tumours

Updates from the BCON trial: Longterm outcomes of hypoxia modification in bladder preservation

Adjuvant sequential chemotherapy plus radiotherapy for LABC after radical cystectomy: Urothelial carcinoma subgroup analysis

KEYNOTE-365 Cohort A: Pembrolizumab plus olaparib in docetaxel-pretreated patients with mCRPC

CheckMate 214: Nivolumab, ipilimumab or sunitinib in patients with advanced renal cell carcinoma

STREAM trial: Enzalutamide and androgen deprivation therapy with salvage radiation in men with high-risk PSA recurrent PC

Analysis of acute toxicity from PACE-B: Comparing SBRT to CFMHRT for localised prostate cancer

KEYNOTE-426: Pembrolizumab and axitinib vs sunitinib in advanced renal cell carcinoma

ASCO GU 2019 renal highlights

ARCHES trial: Androgen deprivation therapy with enzalutamide or placebo in mHSPC

Latest from Tivo-3: Tivozanib for refractory advanced renal cell carcinoma

Whole genome and transcriptome analysis of metastatic adrenocortical carcinoma